| Literature DB >> 31483071 |
Meichen Ma1,2,3,4, Xiaowan Yin1,2,3,4, Xue Zhao1,2,3,4, Chenxi Guo1,2,3,4, Xiaoyu Zhu1,2,3,4, Tingting Liu1,2,3,4, Mei Yang1,2,3,4, Zining Zhang1,2,3,4, Yajing Fu1,2,3,4, Jing Liu1,2,3,4, Junjie Xu1,2,3,4, Haibo Ding1,2,3,4, Xiaoxu Han1,2,3,4, Zhenxing Chu1,2,3,4, Hong Shang1,2,3,4, Yongjun Jiang1,2,3,4.
Abstract
The percentage of human CD56- CD16+ NK cells increases during chronic infection with human HIV; however, the biologic role of CD56- CD16+ NK cells in HIV infection is unclear. Our results demonstrate that the percentage of CD56- CD16+ NK cells producing IL-10 and TGF-β was higher than CD56dim CD16+ NK cells. CD56- CD16+ NK cells could inhibit IFN-γ production by autologous CD8+ T cells, and this inhibition could be partially reversed by anti-IL-10, anti-TGF-β, or anti-PD-L1 mAbs. CD56- CD16+ NK cells are potential targets for the development of novel immune therapies against HIV infection. ©2019 Society for Leukocyte Biology.Entities:
Keywords: IL-10; NK; PD-L1; TGF-β
Mesh:
Substances:
Year: 2019 PMID: 31483071 DOI: 10.1002/JLB.3A0819-171RR
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962